Neuromedin S vs Xenopsin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Neuromedin S (NMS) is a 36-amino acid amidated neuropeptide discovered in 2005 that shares a C-terminal amino acid sequence with neuromedin U (NMU) and activates the same NMUR1 and NMUR2 receptors. However, NMS has a markedly different expression pattern: while NMU is broadly exp...
Calculate Neuromedin S dose →Xenopsin is an octapeptide originally isolated from the skin of the South African clawed frog Xenopus laevis. It shares structural similarity with the C-terminal portion of neurotensin and activates neurotensin receptors....
Calculate Xenopsin dose →| Parameter | Neuromedin S | Xenopsin |
|---|---|---|
| Category | Neuropeptide | Neuropeptide |
| Research | Research | Preclinical |
| Half-Life | Short (minutes, estimated) | Short |
| Typical Dose | 1-10 nmol (central, animal) | N/A (research) |
| Frequency | Variable | N/A |
| Route | Intracerebroventricular, Subcutaneous | IV / ICV (research) |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.